Education
About Us
Working with TipRanks
Follow Us
Electromedical Technologies (EMED)
OTHER OTC:EMED
EMED Stock Chart & Stats
<$0.01
>-$0.01(-7.69%)
At close: 4:00 PM EST
<$0.01
>-$0.01(-7.69%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume90.36M
Average Volume (3M)N/A
Market Cap
$746.46K
Enterprise Value$934.89K
Total Cash (Recent Filing)$14.87K
Total Debt (Recent Filing)$778.75K
Price to Earnings (P/E)―
Beta1.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,732,294,200
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.44
P/FCF Ratio-2.31
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue19.72
Enterprise Value/Gross Profit-42.41
Enterprise Value/Ebitda-1.60
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ModelThe diverse revenue model with direct sales, leasing, and subscriptions provides multiple income streams, enhancing financial resilience and adaptability to market changes.
Strategic PartnershipsPartnerships expand market reach and product accessibility, potentially driving long-term growth by increasing brand visibility and customer base.
Cash Flow ImprovementThe significant improvement in free cash flow indicates better cash management, which can support operations and investments in growth initiatives.
Bears Say
Negative ProfitabilityThe substantial negative profit margin reflects ongoing operational inefficiencies, which could hinder the company's ability to achieve sustainable profitability.
High LeverageHigh leverage and negative equity pose solvency risks, limiting financial flexibility and increasing vulnerability to economic downturns.
Negative Operating Cash FlowPersistent negative operating cash flow indicates ongoing challenges in generating sufficient cash from core operations, impacting long-term financial health.
EMED FAQ
What was Electromedical Technologies’s price range in the past 12 months?
Currently, no data Available
What is Electromedical Technologies’s market cap?
Electromedical Technologies’s market cap is $746.46K.
When is Electromedical Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Electromedical Technologies’s earnings last quarter?
Currently, no data Available
Is Electromedical Technologies overvalued?
According to Wall Street analysts Electromedical Technologies’s price is currently Overvalued.
Does Electromedical Technologies pay dividends?
Electromedical Technologies does not currently pay dividends.
What is Electromedical Technologies’s EPS estimate?
Electromedical Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Electromedical Technologies have?
Electromedical Technologies has 3,732,294,200 shares outstanding.
What happened to Electromedical Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Electromedical Technologies?
Currently, no hedge funds are holding shares in EMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Electromedical Technologies
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company was founded in 2002 and is headquartered in Scottsdale, Arizona.